Samorita Hospital Ltd.
DDSE:SAMORITA87.00
BDT
+0.10
(+0.12%)
ISIN
BD0553SMHOS8
Return %
Stock
S&P 500
1Y
16.47
14.20
3Y
22.69
81.12
5Y
23.60
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- A. B. M. Haroon
- Full Time Employees
- 578
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- Dhaka Bangladesh
- Website
- samoritahospital.org
- Similar Companies
- Business
- Samorita Hospital Ltd. is a Bangladesh-based healthcare provider primarily engaged in delivering comprehensive inpatient, outpatient, diagnostic, and therapeutic medical services. Founded in 1984 and headquartered in Dhaka, Bangladesh, the company is publicly traded on the Dhaka Stock Exchange under the ticker SAMORITA and operates multi-disciplinary medical facilities catering to individual patients, corporate clients, and institutional healthcare seekers across the region. The company operates across four primary business segments: Medical Services, Diagnostic Services, Pharmacy Operations, and Hospital Support Services. Its core clinical and specialized healthcare portfolio includes consultation and inpatient care across general medicine, cardiology, neurology, endocrinology, gastroenterology, nephrology, pulmonology, oncology, and psychiatry; surgical interventions covering general surgery, minimally invasive laparoscopic surgery, orthopedic and trauma surgery, urology, neurosurgery, plastic and reconstructive surgery, pediatric surgery, and otolaryngology (ENT); maternal and child healthcare including obstetrics, gynecology, infertility care, and pediatrics; critical care services through dedicated Intensive Care Units (ICU), Coronary Care Units (CCU), and Neonatal Intensive Care Units (NICU); continuous 24-hour emergency and trauma response; diagnostic imaging and laboratory services featuring computed tomography (CT) scanning, digital radiography (X-ray), ultrasonography, echocardiography, electrocardiography (ECG), electroencephalography (EEG), endoscopy, colonoscopy, and automated clinical pathology; in-house retail and institutional pharmacy operations dispensing prescription medications and medical supplies; and specialized treatment units providing hemodialysis, physiotherapy, and post-operative rehabilitation. In recent operational developments, Samorita Hospital Ltd. has undertaken strategic infrastructure and service expansion initiatives to modernize clinical capabilities and accommodate growing patient demand, including plans for an eight-storey annex building adjacent to its Panthapath complex dedicated to expanded consultant suites, specialized physiotherapy, and a modern chemotherapy unit. Furthermore, the company established a strategic partnership with digital healthcare platform Shastho Limited to expand patient outreach, streamline appointment booking and teleconsultation channels, and enhance the accessibility of its diagnostic and clinical services.